Efficacy and safety of Kamishoyosan in patients with climacteric symptom associated with depressive state
- Conditions
- Climacteric symptom
- Registration Number
- JPRN-UMIN000003429
- Lead Sponsor
- niversity hospital, Hirosaki University School of Medicine Dept. of Obstetrics & Gynecology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Not provided
1)Patients with Major Depressive Episode according to the DSM-IV diagnostic criteria 2)Patients with a history of psychiatric disease 3)Patients who have undergone oophorectomy within the last 6 months 4)Patients who have taken neurological drugs (antianxiety drugs, sedative hypnotics, antiepileptic drugs, analeptics/psychostimulants, antiparkinson drugs, psychoneurological drugs, autonomic drugs (benzodiazepines, and antidepressants), and/or Kampo medicine within 2 weeks before enrollment 5)Patients who have used estrogens and gestagens within 4 weeks before enrollment 6)Patients with serious complications (e.g., hepatic, renal, cardiac, pulmonary, hematological, or metabolic diseases) 7)Patients with a history of drug allergy 8)Patients who have been treated with any investigational drug or will participate in a clinical trial within 4 weeks before enrollment 9)Patients for whom paroxetine is contraindicated 10)Other patients who are assessed to be inappropriate for study participation by the investigator, or other relevant persons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method